423 related articles for article (PubMed ID: 9094628)
1. Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells.
Bassuk AG; Anandappa RT; Leiden JM
J Virol; 1997 May; 71(5):3563-73. PubMed ID: 9094628
[TBL] [Abstract][Full Text] [Related]
2. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter.
Sica A; Dorman L; Viggiano V; Cippitelli M; Ghosh P; Rice N; Young HA
J Biol Chem; 1997 Nov; 272(48):30412-20. PubMed ID: 9374532
[TBL] [Abstract][Full Text] [Related]
3. T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region.
Lemieux AM; Paré ME; Audet B; Legault E; Lefort S; Boucher N; Landry S; van Opijnen T; Berkhout B; Naghavi MH; Tremblay MJ; Barbeau B
J Biol Chem; 2004 Dec; 279(51):52949-60. PubMed ID: 15466412
[TBL] [Abstract][Full Text] [Related]
4. cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.
Thompson CB; Wang CY; Ho IC; Bohjanen PR; Petryniak B; June CH; Miesfeldt S; Zhang L; Nabel GJ; Karpinski B
Mol Cell Biol; 1992 Mar; 12(3):1043-53. PubMed ID: 1545787
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Ets-1 DNA binding and ternary complex formation between Ets-1, NF-kappaB, and DNA by a designed DNA-binding ligand.
Dickinson LA; Trauger JW; Baird EE; Dervan PB; Graves BJ; Gottesfeld JM
J Biol Chem; 1999 Apr; 274(18):12765-73. PubMed ID: 10212261
[TBL] [Abstract][Full Text] [Related]
6. Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells.
Sieweke MH; Tekotte H; Jarosch U; Graf T
EMBO J; 1998 Mar; 17(6):1728-39. PubMed ID: 9501094
[TBL] [Abstract][Full Text] [Related]
7. A direct physical association between ETS and AP-1 transcription factors in normal human T cells.
Bassuk AG; Leiden JM
Immunity; 1995 Aug; 3(2):223-37. PubMed ID: 7648395
[TBL] [Abstract][Full Text] [Related]
8. Identification of three NFAT binding motifs in the 5'-upstream region of the human CD3gamma gene that differentially bind NFATc1, NFATc2, and NF-kappa B p50.
Badran BM; Wolinsky SM; Burny A; Willard-Gallo KE
J Biol Chem; 2002 Dec; 277(49):47136-48. PubMed ID: 12374807
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.
Chan YJ; Chiou CJ; Huang Q; Hayward GS
J Virol; 1996 Dec; 70(12):8590-605. PubMed ID: 8970984
[TBL] [Abstract][Full Text] [Related]
10. Unusual Rel-like architecture in the DNA-binding domain of the transcription factor NFATc.
Wolfe SA; Zhou P; Dötsch V; Chen L; You A; Ho SN; Crabtree GR; Wagner G; Verdine GL
Nature; 1997 Jan; 385(6612):172-6. PubMed ID: 8990122
[TBL] [Abstract][Full Text] [Related]
11. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50.
Torgerson TR; Colosia AD; Donahue JP; Lin YZ; Hawiger J
J Immunol; 1998 Dec; 161(11):6084-92. PubMed ID: 9834092
[TBL] [Abstract][Full Text] [Related]
12. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA; Sun SC; Greene WC; Ballard DW
Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
[TBL] [Abstract][Full Text] [Related]
13. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
Sun W; Graves BJ; Speck NA
J Virol; 1995 Aug; 69(8):4941-9. PubMed ID: 7609063
[TBL] [Abstract][Full Text] [Related]
14. Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.
Ruocco MR; Chen X; Ambrosino C; Dragonetti E; Liu W; Mallardo M; De Falco G; Palmieri C; Franzoso G; Quinto I; Venuta S; Scala G
J Biol Chem; 1996 Sep; 271(37):22479-86. PubMed ID: 8798413
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors.
Eberhardt W; Schulze M; Engels C; Klasmeier E; Pfeilschifter J
Mol Endocrinol; 2002 Aug; 16(8):1752-66. PubMed ID: 12145332
[TBL] [Abstract][Full Text] [Related]
16. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro.
Sheridan PL; Sheline CT; Cannon K; Voz ML; Pazin MJ; Kadonaga JT; Jones KA
Genes Dev; 1995 Sep; 9(17):2090-104. PubMed ID: 7657162
[TBL] [Abstract][Full Text] [Related]
17. A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-kappaB and NFAT families.
de Lumley M; Hart DJ; Cooper MA; Symeonides S; Blackburn JM
J Mol Biol; 2004 Jun; 339(5):1059-75. PubMed ID: 15178248
[TBL] [Abstract][Full Text] [Related]
18. Evolutionarily conserved Ets family members display distinct DNA binding specificities.
Wang CY; Petryniak B; Ho IC; Thompson CB; Leiden JM
J Exp Med; 1992 May; 175(5):1391-9. PubMed ID: 1569404
[TBL] [Abstract][Full Text] [Related]
19. A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells.
Leiden JM; Wang CY; Petryniak B; Markovitz DM; Nabel GJ; Thompson CB
J Virol; 1992 Oct; 66(10):5890-7. PubMed ID: 1527846
[TBL] [Abstract][Full Text] [Related]
20. Divergent effects of dithiocarbamates on AP-1-containing and AP-1-less NFAT sites.
Saccani S; Saccani A; Varesio L; Ghosh P; Young HA; Sica A
Eur J Immunol; 1999 Apr; 29(4):1194-201. PubMed ID: 10229086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
